Untitled

Loading Events
Find Webinars

Event Views Navigation

May 2022

“Rising Pressures on Rising Drug Costs in the United States”

HealthTrust presents..."Rising Pressures on Rising Drug Costs in the United States" https://share.vidyard.com/watch/GU6SAchrM2c2MLhK9VARTw? Download the content. Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. It has been reported U.S. drug sales are about two-times more than the rest of the world combined on the top 20 selling drugs worldwide. This presentation will showcase how U.S. drug prices compare to those in other countries, the role…

Find out more »

“The FDA Bad Ad Program and Prescription Drug Promotion”

The U.S. Food and Drug Administration (FDA)* through a contract from the U.S. Department of Health and Human Services presents..."The FDA Bad Ad Program and Prescription Drug Promotion" This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation's healthcare professionals about prescription drug advertising and promotion. Learning Objectives  |  Upon completion of this activity, participants will be able to: Identify the role that FDA’s Office of Prescription Drug…

Find out more »

On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration's (FDA) Division of Drug Information* presents... Educational Webinars for Healthcare Professionals FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) sponsors a series of educational webinars targeting the needs of healthcare professionals and students. The webinars cover a broad range of FDA drug regulation and medication safety topics. These focused webinars support FDA's mission of promoting and protecting public health through interaction and education to strengthen current and future…

Find out more »

“Euglycemic Diabetic Ketoacidosis in Setting of SGLT2 Inhibitor Use”

HealthTrust presents...“Euglycemic Diabetic Ketoacidosis in Setting of SGLT2 Inhibitor Use” https://share.vidyard.com/watch/hMWXvGBoV7TWztwnLViALL? Download the content. Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. This presentation is on euglycemic diabetic ketoacidosis in setting of SGLT2 inhibitor use. Pathophysiology of diabetic ketoacidosis and euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors will be discussed and diagnostic criteria and laboratory findings associated with diabetic ketoacidosis and analyze literature available…

Find out more »

“Prevention and Treatment of Cancer-Related Infections in Adult Patients”

HealthTrust presents...“Prevention and Treatment of Cancer-Related Infections in Adult Patients” https://share.vidyard.com/watch/pyNdXXf8Lz1DqASQGd2etR?   Download the content. Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. This presentation will provide education on evidence-based guideline recommendations for prophylaxis and treatment of cancer related infections. It will review risk stratifications of patients' risks based on patient characteristics, recommendations of appropriate pharmacotherapies for prophylaxis based on risks and recommend appropriate…

Find out more »

April 2022

On Demand: “Balancing the Wound Environment: ORC/Collagen/Silver-ORC Dressings”

Center for Healing Solutions & 3M Health Care Academy* present...Balancing the Wound Environment: ORC/Collagen/Silver-ORC Dressings" Target audience:  This activity is designed for clinicians involved in the management of patients with, or at risk of, developing chronic wounds. Learning Objectives | After participating in this activity, learners should be better able to: Examine the clinical impact of ORC and addition of silver-ORC in the wound environment Determine when to use ORC/collagen/silver-ORC dressings and who to use it on Examine, via cases, the…

Find out more »

“Updates in the Pharmacotherapy of Alcohol Withdrawal Management in the Outpatient and Inpatient Settings”

HealthTrust presents...“Updates in the Pharmacotherapy of Alcohol Withdrawal Management in the Outpatient and Inpatient Settings” https://share.vidyard.com/watch/QA9ct3NMUMmT1DmD5xv7yr? Download the content. Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. In 2020, the American Society of Addiction Medicine (ASAM) released a new guideline on alcohol withdrawal management. Since the last update of the 2004 guideline, numerous clinical questions and research have emerged. Additionally, while literature has focused…

Find out more »

On-Demand CE program: “Disaster Medicine: Sepsis”

Sepsis Alliance* presents…"Disaster Medicine: Sepsis" Course expires: date not available Populations affected by disasters are exposed to a variety of health hazards such as trauma, burns, poor sanitation, and mass sheltering, all of which place them at increased risk of infection and sepsis. Under the resource-limited conditions typical of disaster zones, the clinical identification and management of sepsis can be more challenging compared to normal operating conditions in conventional health care settings. This training module will provide guidance on how to…

Find out more »

“Management and Advancements in Sickle Cell Disease”

HealthTrust presents..."Management and Advancements in Sickle Cell Disease" https://share.vidyard.com/watch/r1sdKbVRsGVFVTEAZAnHgh?   Download the content. Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. In this presentation, the pathophysiology and management of sickle cell disease will be reviewed. Key components of the current guideline recommendations will be discussed with a highlight on pharmacology of pertinent prescription agents. Recent literature regarding new therapeutic options such as monoclonal antibodies…

Find out more »

“The FDA Bad Ad Program and Prescription Drug Promotion”

The U.S. Food and Drug Administration (FDA)* through a contract from the U.S. Department of Health and Human Services presents..."The FDA Bad Ad Program and Prescription Drug Promotion" This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation's healthcare professionals about prescription drug advertising and promotion. Learning Objectives  |  Upon completion of this activity, participants will be able to: Identify the role that FDA’s Office of Prescription Drug…

Find out more »
+ Export Events